Viewing Study NCT00894868

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-02-23 @ 1:53 PM
Study NCT ID: NCT00894868
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2009-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Congestive Heart Failure View
None Type II Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Congestive Heart Failure View
None CHF, vildagliptin View
None metabolic disease View
None cardiovascular disease View
None T2DM View